An Observational, Prospective Study to Assess the Efficacy and Safety of Adalloce in Patients With Rheumatoid Arthritis and Ankylosing Spondylitis
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
This Study is to Assess the Efficacy and Safety of Adalloce in Patients With Rheumatoid Arthritis and Ankylosing Spondylitis, An Observational, Prospective Study
Eligibility
Participation Requirements
Sex: All
Minimum Age: 19
Maximum Age: 74
Healthy Volunteers: f
View:
• Men and women between the ages of over 19 and under 75 at the time of consent
• Patients diagnosed with RA or AS at least 3 months prior to the study registration
• Patients who are scheduled to be prescribed Adalloce according to the doctor's opinions
• Patients who have never received Adalloce
• Patients who voluntarily gave their written consent after being sufficiently explained about the purpose and contents of this study
Locations
Other Locations
Republic of Korea
Daegu Catholic University Medical Center
RECRUITING
Daegu
Contact Information
Primary
Hee Suh
hee1110@yuhan.co.kr
+82-2-828-0231
Time Frame
Start Date: 2023-01-26
Estimated Completion Date: 2026-08
Participants
Target number of participants: 1000
Related Therapeutic Areas
Sponsors
Leads: Yuhan Corporation